Skip to main content
WANGATA EBOLA TREATMENT CENTRE

Haemorrhagic fevers

Ebola, Lassa and Marburg haemorrhagic fevers are rare but deadly, spreading fear and panic. Caring for infected patients and affected communities is crucial for a response to be effective.

Outbreaks can kill 25 to 90 per cent of those infected. Until recently, there were no tools to prevent or treat Ebola; today a preventive vaccine and curative drugs are available. MSF has responded in almost all reported outbreaks over the past years.

The 2014-2016 Ebola epidemic in West Africa was unprecedented: 67 times the size of the largest previously recorded outbreak, it reached urban areas, and killed more than 11,300 people. Hundreds of health workers died, decimating the already-struggling healthcare systems of Liberia, Guinea and Sierra Leone.

Since then, the Democratic Republic of Congo has experienced a succession of outbreaks since March 2018.

Quick facts about Ebola and Marburg

 
Haemorrhagic fevers

Ebola: providing care to the care givers

Project Update 27 Oct 2000
 
Uganda

Ebola outbreak

Press Release 19 Oct 2000
 
Haemorrhagic fevers

WHO Fact Sheet - Ebola Haemorrhagic Fever

Project Update 17 Oct 2000
 
Uganda

Ebola outbreak: MSF sends first team

Project Update 17 Oct 2000
 
Haemorrhagic fevers

Ebola information - 2000

Project Update 16 Oct 2000
 
Haemorrhagic fevers

How ebola kills

Project Update 28 Sep 2000
 
Haemorrhagic fevers

Ebola: The start

Project Update 28 Sep 2000
Advanced HIV management in Homa Bay
Medical Resource

MSF Field Research

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. All of these articles can be found on our dedicated Field Research website.

Visit site